ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/28 | 2,500 | 2,540 | 2,473 | 2,514 | +20 | +0.8% | 93,300 |
2018/09/27 | 2,519 | 2,541 | 2,483 | 2,494 | -50 | -2% | 82,900 |
2018/09/26 | 2,513 | 2,548 | 2,508 | 2,544 | -12 | -0.5% | 101,100 |
2018/09/25 | 2,452 | 2,558 | 2,450 | 2,556 | +129 | +5.3% | 233,200 |
2018/09/21 | 2,440 | 2,441 | 2,407 | 2,427 | +8 | +0.3% | 109,900 |
2018/09/20 | 2,462 | 2,462 | 2,405 | 2,419 | -37 | -1.5% | 81,400 |
2018/09/19 | 2,420 | 2,470 | 2,409 | 2,456 | +51 | +2.1% | 102,400 |
2018/09/18 | 2,372 | 2,410 | 2,341 | 2,405 | +23 | +1% | 74,300 |
2018/09/14 | 2,378 | 2,404 | 2,369 | 2,382 | +25 | +1.1% | 102,000 |
2018/09/13 | 2,336 | 2,384 | 2,335 | 2,357 | +28 | +1.2% | 43,700 |
2018/09/12 | 2,349 | 2,349 | 2,297 | 2,329 | -23 | -1% | 64,900 |
2018/09/11 | 2,344 | 2,356 | 2,326 | 2,352 | +9 | +0.4% | 45,500 |
2018/09/10 | 2,357 | 2,390 | 2,337 | 2,343 | -16 | -0.7% | 44,600 |
2018/09/07 | 2,358 | 2,379 | 2,335 | 2,359 | +1 | ±0% | 45,900 |
2018/09/06 | 2,376 | 2,376 | 2,348 | 2,358 | -19 | -0.8% | 40,100 |
2018/09/05 | 2,416 | 2,416 | 2,365 | 2,377 | -36 | -1.5% | 49,100 |
2018/09/04 | 2,398 | 2,422 | 2,362 | 2,413 | +21 | +0.9% | 49,600 |
2018/09/03 | 2,382 | 2,395 | 2,359 | 2,392 | +10 | +0.4% | 50,900 |
2018/08/31 | 2,390 | 2,392 | 2,366 | 2,382 | -19 | -0.8% | 50,900 |
2018/08/30 | 2,478 | 2,478 | 2,391 | 2,401 | -56 | -2.3% | 69,300 |
2018/08/29 | 2,400 | 2,464 | 2,393 | 2,457 | +67 | +2.8% | 105,500 |
2018/08/28 | 2,410 | 2,426 | 2,386 | 2,390 | +3 | +0.1% | 69,800 |
2018/08/27 | 2,355 | 2,389 | 2,346 | 2,387 | +46 | +2% | 60,800 |
2018/08/24 | 2,368 | 2,388 | 2,335 | 2,341 | +2 | +0.1% | 55,600 |
2018/08/23 | 2,324 | 2,364 | 2,322 | 2,339 | +25 | +1.1% | 55,100 |
2018/08/22 | 2,325 | 2,331 | 2,314 | 2,314 | -21 | -0.9% | 47,400 |
2018/08/21 | 2,307 | 2,342 | 2,305 | 2,335 | +28 | +1.2% | 39,600 |
2018/08/20 | 2,315 | 2,320 | 2,296 | 2,307 | -27 | -1.2% | 79,300 |
2018/08/17 | 2,310 | 2,337 | 2,302 | 2,334 | +24 | +1% | 32,800 |
2018/08/16 | 2,333 | 2,345 | 2,306 | 2,310 | -66 | -2.8% | 78,400 |
2018/08/15 | 2,398 | 2,449 | 2,371 | 2,376 | -50 | -2.1% | 67,200 |
2018/08/14 | 2,372 | 2,427 | 2,372 | 2,426 | +58 | +2.4% | 40,500 |
2018/08/13 | 2,421 | 2,423 | 2,354 | 2,368 | -67 | -2.8% | 66,600 |
2018/08/10 | 2,469 | 2,479 | 2,425 | 2,435 | -34 | -1.4% | 70,800 |
2018/08/09 | 2,500 | 2,524 | 2,454 | 2,469 | -45 | -1.8% | 103,500 |
2018/08/08 | 2,553 | 2,567 | 2,514 | 2,514 | -42 | -1.6% | 135,800 |
2018/08/07 | 2,587 | 2,640 | 2,547 | 2,556 | -76 | -2.9% | 183,500 |
2018/08/06 | 2,484 | 2,677 | 2,484 | 2,632 | +248 | +10.4% | 367,200 |
2018/08/03 | 2,427 | 2,427 | 2,350 | 2,384 | -37 | -1.5% | 68,600 |
2018/08/02 | 2,403 | 2,442 | 2,385 | 2,421 | +18 | +0.7% | 89,500 |
2018/08/01 | 2,500 | 2,519 | 2,396 | 2,403 | -69 | -2.8% | 118,200 |
2018/07/31 | 2,404 | 2,544 | 2,337 | 2,472 | +46 | +1.9% | 563,500 |
2018/07/30 | 2,385 | 2,431 | 2,381 | 2,426 | +26 | +1.1% | 112,400 |
2018/07/27 | 2,343 | 2,416 | 2,334 | 2,400 | +57 | +2.4% | 162,800 |
2018/07/26 | 2,262 | 2,343 | 2,261 | 2,343 | +89 | +3.9% | 140,200 |
2018/07/25 | 2,288 | 2,288 | 2,251 | 2,254 | -21 | -0.9% | 45,500 |
2018/07/24 | 2,296 | 2,304 | 2,270 | 2,275 | -16 | -0.7% | 58,600 |
2018/07/23 | 2,302 | 2,311 | 2,283 | 2,291 | -11 | -0.5% | 38,400 |
2018/07/20 | 2,321 | 2,331 | 2,291 | 2,302 | -19 | -0.8% | 42,400 |
2018/07/19 | 2,354 | 2,354 | 2,318 | 2,321 | -34 | -1.4% | 48,900 |
1501~
1550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 225,400円 | +13.6% | +29.2% | 2.04% | 11.69倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 482,500円 | +12.0% | +28.1% | 2.49% | 26.60倍 | 1.13倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,000円 | +3.0% | +27.5% | 2.42% | 20.96倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 116,100円 | +197.7% | - | 0.00% | 47.45倍 | 1.52倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム